Phase 2 Trial of Metastasis Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S256-S257
DOI: 10.1016/j.ijrobp.2026.06.544 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von R. Glicksman und 26 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Glicksman, R., Metser, U., Ye, X., Chung, P., Ramotar, M., Shin, C., Labbe, M., Murad, V., Hamilton, R., Finelli, A., Fleshner, N., Perlis, N., Kulkarni, G., Zlotta, A., Bayley, A., Helou, J., Raman, S., Catton, C., McPartlin, A., …, & Berlin, A. (2026). Phase 2 Trial of Metastasis Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics, 126(1), S256-S257. https://doi.org/10.1016/j.ijrobp.2026.06.544
Vancouver
Glicksman R, Metser U, Ye X, Chung P, Ramotar M, Shin C, et al. Phase 2 Trial of Metastasis Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S256-S257. doi:10.1016/j.ijrobp.2026.06.544
BibTeX
@article{Glicksman2026,
author = {Glicksman, R. and Metser, U. and Ye, X.Y. and Chung, P.W.M. and Ramotar, M. and Shin, C. and Labbe, M. and Murad, V. and Hamilton, R.J. and Finelli, A. and Fleshner, N.E. and Perlis, N. and Kulkarni, G.S. and Zlotta, A. and Bayley, A. and Helou, J. and Raman, S. and Catton, C. and McPartlin, A. and Mesci, A. and Said, B. Id and Winter, J.D. and Dang, J. and Warde, P.R. and Gospodarowicz, M.K. and Jaffray, D.A. and Berlin, A.},
title = {Phase 2 Trial of Metastasis Directed Therapy for Molecularly Defined Oligometastatic Prostate Cancer},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S256--S257},
doi = {10.1016/j.ijrobp.2026.06.544}
}
EUVIMED